ND UBS (LUX) BOND SICAV - USD INVESTMENT GRADE CORPORATES (USD) Q-ACC | 21/07 | 2,86% |
| **** UBS (LUX) CREDIT INCOME (CHF HEDGED) I-A1-ACC | 20/07 | -0,21% |
| ** UBS (LUX) CREDIT INCOME (CHF HEDGED) Q-DIST | 20/07 | -2,45% |
| ***** UBS (LUX) CREDIT INCOME (EUR HEDGED) I-A1-ACC | 20/07 | 0,22% |
| ***** UBS (LUX) CREDIT INCOME (EUR HEDGED) I-B-ACC | 20/07 | 0,48% |
| ***** UBS (LUX) CREDIT INCOME (EUR HEDGED) K-1-ACC | 20/07 | 0,19% |
| ***** UBS (LUX) CREDIT INCOME (EUR HEDGED) P-ACC | 20/07 | 0,02% |
| * UBS (LUX) CREDIT INCOME (EUR HEDGED) P-QDIST | 20/07 | -2,04% |
| ***** UBS (LUX) CREDIT INCOME (EUR HEDGED) Q-ACC | 20/07 | 0,14% |
| * UBS (LUX) CREDIT INCOME (EUR HEDGED) Q-QDIST | 20/07 | -2,04% |
| ***** UBS (LUX) CREDIT INCOME (GBP HEDGED) K-1-ACC | 20/07 | 3,95% |
| **** UBS (LUX) CREDIT INCOME I-A1-ACC | 20/07 | 3,98% |
| **** UBS (LUX) CREDIT INCOME I-B-ACC | 20/07 | 4,36% |
| **** UBS (LUX) CREDIT INCOME K-1-ACC | 20/07 | 3,96% |
| ** UBS (LUX) CREDIT INCOME K-1-QDIST | 20/07 | 1,72% |
| *** UBS (LUX) CREDIT INCOME P-ACC | 20/07 | 3,79% |
| ** UBS (LUX) CREDIT INCOME P-QDIST | 20/07 | 1,70% |
| **** UBS (LUX) CREDIT INCOME Q-ACC | 20/07 | 3,90% |
| ** UBS (LUX) CREDIT INCOME Q-QDIST | 20/07 | 1,71% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY (CHF HEDGED) I-A1-ACC | 20/07 | -4,20% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY (CHF HEDGED) P-ACC | 20/07 | -4,68% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY (CHF HEDGED) Q-ACC | 20/07 | -4,23% |
| ND UBS (LUX) DIGITAL HEALTH EQUITY (CHF HEDGED) QL-ACC | 20/07 | -4,13% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY (EUR HEDGED) I-A1-ACC | 20/07 | -3,97% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY (EUR HEDGED) K-1-ACC | 20/07 | -4,06% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY (EUR HEDGED) P-ACC | 20/07 | -4,44% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY (EUR HEDGED) Q-ACC | 20/07 | -3,98% |
| ND UBS (LUX) DIGITAL HEALTH EQUITY (EUR HEDGED) QL-ACC | 20/07 | -3,90% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY (EUR) P-DIST | 20/07 | -0,51% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY (EUR) Q-ACC | 20/07 | -0,04% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY (GBP HEDGED) Q-ACC | 20/07 | -0,20% |
| ND UBS (LUX) DIGITAL HEALTH EQUITY (GBP HEDGED) QL-ACC | 20/07 | -0,11% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY I-A1-ACC | 20/07 | -0,14% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY I-A2-ACC | 20/07 | -0,12% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY I-B-ACC | 20/07 | 0,28% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY K-1-ACC | 20/07 | -0,26% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY N-ACC | 20/07 | -1,34% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY P-ACC | 20/07 | -0,64% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY Q-ACC | 20/07 | -0,16% |
| ND UBS (LUX) DIGITAL HEALTH EQUITY QL-ACC | 20/07 | -0,06% |
| ** UBS (LUX) DIGITAL HEALTH EQUITY SEEDING P-ACC | 20/07 | 0,02% |
| **** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (CHF HEDGED) P-ACC | 21/07 | 1,28% |
| ** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (CHF HEDGED) P-DIST | 21/07 | 1,28% |
| ** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (CHF HEDGED) Q-DIST | 21/07 | 1,69% |
| ND UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (CHF HEDGED) QL-DIST | 21/07 | 1,85% |
| **** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (EUR HEDGED) P-ACC | 21/07 | 1,95% |
| ND UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) (EUR HEDGED) QL-ACC | 21/07 | 2,53% |
| ***** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) F-ACC | 21/07 | 6,57% |
| ***** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) I-A1-ACC | 21/07 | 6,46% |
| ***** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) I-B-ACC | 21/07 | 6,80% |
| ***** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) I-X-ACC | 21/07 | 6,87% |
| **** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) P-ACC | 21/07 | 5,94% |
| ** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) P-MDIST | 21/07 | 0,54% |
| ***** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) Q-ACC | 21/07 | 6,37% |
| *** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) Q-DIST | 21/07 | 6,38% |
| ND UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) QL-ACC | 21/07 | 6,55% |
| ND UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) QL-DIST | 21/07 | 6,54% |
| ***** UBS (LUX) EMERGING ECONOMIES FUND - SOVEREIGN BONDS (USD) U-X-ACC | 21/07 | 6,87% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) I-A1-ACC | 20/07 | -1,27% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) I-B-ACC | 20/07 | -1,01% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) K-1-ACC | 20/07 | -1,33% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (CHF HEDGED) P-ACC | 20/07 | -1,62% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) I-A1-ACC | 20/07 | -0,85% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) I-B-DIST | 20/07 | -0,58% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) K-1-ACC | 20/07 | -0,93% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) P-ACC | 20/07 | -1,22% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND (EUR HEDGED) Q-ACC | 20/07 | -1,00% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A1-ACC | 20/07 | 2,92% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-A2-ACC | 20/07 | 2,98% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-ACC | 20/07 | 3,20% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND I-B-DIST | 20/07 | 3,20% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-ACC | 20/07 | 2,85% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND K-1-DIST | 20/07 | 2,84% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND P-ACC | 20/07 | 2,56% |
| ND UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | 20/07 | 2,79% |
| *** UBS (LUX) EQUITY FUND - BIOTECH (USD) (EUR) Q-ACC | 30/06 | 20,52% |
| *** UBS (LUX) EQUITY FUND - BIOTECH (USD) P-ACC | 21/07 | 16,70% |
| *** UBS (LUX) EQUITY FUND - BIOTECH (USD) Q-ACC | 21/07 | 17,36% |
| *** UBS (LUX) EQUITY FUND - BIOTECH (USD) QL-ACC | 21/07 | 17,49% |
| * UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) P-ACC | 21/07 | -9,72% |
| * UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR HEDGED) Q-ACC | 21/07 | -9,14% |
| * UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) I-A1-ACC | 21/07 | -5,55% |
| * UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) P-ACC | 21/07 | -6,16% |
| * UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) (EUR) Q-ACC | 21/07 | -5,58% |
| * UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) F-ACC | 21/07 | -5,31% |
| * UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) I-A1-ACC | 21/07 | -5,42% |
| * UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) I-A3-ACC | 21/07 | -5,31% |
| * UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) P-ACC | 21/07 | -6,04% |
| * UBS (LUX) EQUITY FUND - CHINA OPPORTUNITY (USD) Q-ACC | 21/07 | -5,44% |
| **** UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) (CHF HEDGED) P-ACC | 21/07 | 24,19% |
| **** UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) (CHF HEDGED) Q-ACC | 21/07 | 24,84% |
| **** UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) (EUR) N-ACC | 21/07 | 30,06% |
| **** UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) P-ACC | 21/07 | 30,48% |
| **** UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) Q-ACC | 21/07 | 31,16% |
| **** UBS (LUX) EQUITY FUND - EMERGING MARKETS SUSTAINABLE LEADERS (USD) (SGD) P-ACC | 21/07 | 30,36% |
| ** UBS (LUX) EQUITY FUND - EURO COUNTRIES OPPORTUNITY (EUR) P-ACC | 21/07 | 12,89% |
| ** UBS (LUX) EQUITY FUND - EURO COUNTRIES OPPORTUNITY (EUR) Q-ACC | 21/07 | 13,40% |
| ** UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY (EUR) I-A1-ACC | 21/07 | 12,86% |
| ** UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY (EUR) P-ACC | 21/07 | 12,16% |
| ** UBS (LUX) EQUITY FUND - EUROPEAN OPPORTUNITY (EUR) Q-ACC | 21/07 | 12,71% |
